Pharma Spending to Increase in Second Half Of 2005; Will Multi-Platform Vendors Profit? | GenomeWeb

Analysts and participants in the molecular biology tools industry are predicting a stronger pharmaceutical spending market in the second half of 2005, erasing earlier concerns about potential long-term revenue declines for the sector.

The predictions, which come after a turbulent beginning of the year marked by spotty R&D spending and volatile investment in molecular biology tools, may help buoy the multi-platform business sector covered by BioCommerce Week.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: global genetic diversity map, and more.

The Nuffield Council on Bioethics identifies ethical questions to explore surrounding genome editing.

In a blog post, Brigham and Women's Hospital's Robert Green discusses "predispositional personal genome sequencing."

Stat News reports that there's muted opposition to the Kuwaiti DNA database law.